Okay.
Mr. Burt, I have a question around this average person affected as it's viewed in CEPA right now. We've heard testimony at the committee that this does an inadequate job of protecting vulnerable populations. Many colleagues have shared this concern, I think, around the table that if we're not using the right test subject, then we set limits of exposure that are inappropriate. That exposure to infants, newborns, to the elderly, to people who are sick.... If we're not using the appropriate subject, then whatever exposure rates we allow into the environment are inappropriate.
Would Dow be interested and supportive of the committee looking at recommendations to CEPA that would change that test, change that standard from the “average person”?